Persistent leaks” and “unaddressed contamination issues” are among the problems workers say they witnessed at one of the ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

This is an area where competition isn’t as fierce as in diabetes or cardiovascular, giving Abbott room to carve out a leadership position. Beyond products, Abbott’s global footprint remains a ...

Abbott Laboratories (NYSE: ABT) stock was in fine health on the second-to-last trading day of the week, thanks to news from Europe. Investors greeted this positively, rewarding the company with a ...

The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

Abbott’s pulse field ablation system competes with products from Medtronic and Boston Scientific, which also have large ...

The acquisition of St. Jude's heart-focused portfolio significantly broadened Abbott's cardiac device product offering, raising the firm's ability to compete as hospital clients seek to winnow ...

Abbott Laboratories ABT has witnessed strong momentum in the past year. Shares of the company have risen 12.7% compared with the 9% growth of the industry during the same time frame. The S&P 500 ...

Investing in stocks comes with risks. There's no way around that fact. However, some stocks can be less risky than others during certain market conditions. Three Motley Fool contr ...

Although the introduction of that machinery received attention, it's not the only Abbott product used by the hospital. Jessica Giacona, the lab's supervisor, told The Citizen that all of the core ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new trial against the companies.